酪氨酸激酶抑制剂相关治疗药物监测的研究进展(10)
[60] TIAN XB，ZHANG HF，HEIMBACH T，et al. Clinical pharmacokinetic and pharmacodynamic overview of nilotinib，a selective tyrosine kinase inhibitor[J]. J Clin Pharmacol，2018，58(12)：1533-1540.[61] GILES FJ，YIN OQ，SALLAS WM，et al. Nilotinib population pharmacokinetics and exposure-response analysis in patients with imatinib-resistant or -intolerant chronic myeloid leukemia[J]. Eur J Clin Pharmacol ......
您现在查看是摘要页，全文长 2716 字符。